MedPath

Mammography SPECT With Rotating Slant Hole Collimator

Withdrawn
Conditions
Breast Cancer
Registration Number
NCT00328354
Lead Sponsor
Johns Hopkins University
Brief Summary

The goal is to conduct a pilot study to determine the feasibility of the clinical use of RMSSH SPECT imaging technology for breast imaging and to develop a standardized clinical protocol.

Detailed Description

The goal of this protocol is to develop and evaluate a novel SPECT imaging technique for imaging the breast using rotating multi-segment slant-hole (RMSSH) collimators. The motivation is the requirement of a low cost RMSSH collimator and a conventional Large-Field-Of-View (LFOV) camera. It is believed that RMSSH SPECT is particularly suitable for applications in breast imaging.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Women seen at Johns Hopkins Avon Division of Breast Imaging who have been diagnosed with breast cancer.
Exclusion Criteria
  • Pregnant (or possibly pregnant)
  • Lactating
  • Unable to give consent
  • Weights over 300 pounds
  • Women who have already undergone definitive surgical treatment to their breast for breast cancer will not be eligible.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Johns Hopkins Outpatient Center

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath